Amphastar anticipates $2M-$3M per quarter IMS remediation costs while maintaining mid-single digit to high single-digit 2026 sales growth (NASDAQ:AMPH)
· seekingalpha.com
Amphastar (AMPH) Q2 2026 earnings call recap: revenue, BAQSIMI pricing, IMS FDA warning letter impact, guidance & key risks.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...